Ephrin receptor

Last updated
Eph receptor ligand binding domain
EphA5.png
Structure of the kinase domain of human eph type-A receptor 5 (EphA5)
Identifiers
SymbolEphrin_lbd
Pfam PF01404
InterPro IPR016257
SCOP2 1nuk / SCOPe / SUPFAM
CDD cd10319
Membranome 1202
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary

Eph receptors (Ephs, after erythropoietin-producing human hepatocellular receptors) are a group of receptors that are activated in response to binding with Eph receptor-interacting proteins (Ephrins). Ephs form the largest known subfamily of receptor tyrosine kinases (RTKs). Both Eph receptors and their corresponding ephrin ligands are membrane-bound proteins that require direct cell-cell interactions for Eph receptor activation. Eph/ephrin signaling has been implicated in the regulation of a host of processes critical to embryonic development including axon guidance, [1] formation of tissue boundaries, [2] cell migration, and segmentation. [3] Additionally, Eph/ephrin signaling has been identified to play a critical role in the maintenance of several processes during adulthood including long-term potentiation, [4] angiogenesis, [5] and stem cell differentiation and cancer. [6]

Contents

Subclasses

Ephs can be divided into two subclasses, EphAs and EphBs (encoded by the genetic loci designated EPHA and EPHB respectively), based on sequence similarity and on their binding affinity for either the glycosylphosphatidylinositol-linked ephrin-A ligands or the transmembrane-bound ephrin-B ligands. [7] Of the 16 Eph receptors (see above) that have been identified in animals, humans are known to express nine EphAs (EphA1-8 and EphA10) and five EphBs (EphB1-4 and EphB6). [8] In general, Ephs of a particular subclass bind preferentially to all ephrins of the corresponding subclass, but have little to no cross-binding to ephrins of the opposing subclass. [9] It has recently been proposed that the intrasubclass specificity of Eph/ephrin binding could be partially attributed to the different binding mechanisms used by EphAs and EphBs. There are exceptions to the intrasubclass binding specificity observed in Ephs, however, as it has recently been shown that ephrin-B3 can bind to and activate EphA4 and that ephrin-A5 can bind to and activate EphB2. [10] EphA/ephrinA interaction typically occur with higher affinity than EphB/ephrin-B interactions which can partially be attributed to the fact that ephrin-As bind via a "lock-and-key" mechanism that requires little conformational change of the EphAs in contrast to EphBs which utilize an "induced fit" mechanism that requires a greater amount of energy to alter the conformation of EphBs to bind to ephrin-Bs. [11]

16 Ephs have been identified in animals and are listed below:

Activation

The extracellular domain of Eph receptors is composed of a highly conserved globular ephrin ligand-binding domain, a cysteine-rich region and two fibronectin type III domains. The cytoplasmic domain of Eph receptors is composed of a juxtamembrane region with two conserved tyrosine residues, a tyrosine kinase domain, a sterile alpha motif (SAM), and a PDZ-binding motif. [4] [11] Following binding of an ephrin ligand to the extracellular globular domain of an Eph receptor, tyrosine and serine residues in the juxtamembrane region of the Eph become phosphorylated [12] allowing the intracellular tyrosine kinase to convert into its active form and subsequently activate or repress downstream signaling cascades. [13] The structure of the trans-autophosphorylation of the juxtamembrane region of EPHA2 has been observed within a crystal of EPHA2. [14]

Function

The ability of Ephs and ephrins to mediate a variety of cell-cell interactions places the Eph/ephrin system in an ideal position to regulate a variety of different biological processes during embryonic development.

Bi-directional signaling

Unlike most other RTKs, Ephs have a unique capacity to initiate an intercellular signal in both the receptor-bearing cell ("forward" signaling) and the opposing ephrin-bearing cell ("reverse" signaling) following cell-cell contact, which is known as bi-directional signaling. [15] Although the functional consequences of Eph/ephrin bi-directional signaling have not been completely elucidated, it is clear that such a unique signaling process allows for ephrin Ephs to have opposing effects on growth cone survival [16] and allows for the segregation of Eph-expressing cells from ephrin-expressing cells. [17]

Segmentation

Segmentation is a basic process of embryogenesis occurring in most invertebrates and all vertebrates by which the body is initially divided into functional units. In the segmented regions of the embryo, cells begin to present biochemical and morphological boundaries at which cell behavior is drastically different – vital for future differentiation and function. [18] In the hindbrain, segmentation is a precisely defined process. In the paraxial mesoderm, however, development is a dynamic and adaptive process that adjusts according to posterior body growth. Various Eph receptors and ephrins are expressed in these regions, and, through functional analysis, it has been determined that Eph signaling is crucial for the proper development and maintenance of these segment boundaries. [18] Similar studies conducted in zebrafish have shown similar segmenting processes within the somites containing a striped expression pattern of Eph receptors and their ligands, which is vital to proper segmentation - the disruption of expression resulting in misplaced or even absent boundaries. [19]

Axon guidance

As the nervous system develops, the patterning of neuronal connections is established by molecular guides that direct axons (axon guidance) along pathways by target and pathway derived signals. [20] Eph/ephrin signaling regulates the migration of axons to their target destinations largely by decreasing the survival of axonal growth cones and repelling the migrating axon away from the site of Eph/ephrin activation. [16] [21] This mechanism of repelling migrating axons through decreased growth cone survival depends on relative levels of Eph and ephrin expression and allows gradients of Eph and ephrin expression in target cells to direct the migration of axon growth cones based on their own relative levels of Eph and ephrin expression. Typically, forward signaling by both EphA and EphB receptors mediates growth cone collapse while reverse signaling via ephrin-A and ephrin-B induces growth cone survival. [16] [22]

The ability of Eph/ephrin signaling to direct migrating axons along Eph/ephrin expression gradients is evidenced in the formation of the retinotopic map in the visual system, with graded expression levels of both Eph receptors and ephrin ligands leading to the development of a resolved neuronal map [23] (for a more detailed description of Eph/ephrin signaling see "Formation of the Retinotopic Map" in ephrin). Further studies then showed the role of Eph’s in topographic mapping in other regions of the central nervous system, such as learning and memory via the formation of projections between the septum and hippocampus. [24]

In addition to the formation of topographic maps, Eph/ephrin signaling has been implicated in the proper guidance of motor neuron axons in the spinal cord. Although several members of Ephs and ephrins contribute to motor neuron guidance, [25] ephrin-A5 reverse signaling has been shown to play a critical role in the survival of motor neuron growth cones and to mediate growth cone migration by initiating repellence in EphA-expressing migrating axons. [16]

Cell migration

More than just axonal guidance, Ephs have been implicated in the migration of neural crest cells during gastrulation. [26] In the chick and rat embryo trunk, the migration of crest cells is partially mediated by EphB receptors. Similar mechanisms have been shown to control crest movement in the hindbrain within rhombomeres 4, 5, and 7, which distribute crest cells to brachial arches 2, 3, and 4 respectively. In C. elegans a knockout of the vab-1 gene, known to encode an Eph receptor, and its Ephrin ligand vab-2 results in two cell migratory processes being affected. [27] [28]

Angiogenesis

Eph receptors are present in high degrees during vasculogenesis, angiogenesis, and other early development of the circulatory system. This development is disturbed without it. It is thought to distinguish arterial and venous endothelium, stimulating the production of capillary sprouts as well as in the differentiation of mesenchyme into perivascular support cells.

The construction of blood vessels requires the coordination of endothelial and supportive mesenchymal cells through multiple phases to develop the intricate networks required for a fully functional circulatory system. [29] The dynamic nature and expression patterns of the Ephs make them, therefore, ideal for roles in angiogenesis. Mouse embryonic models show expression of EphA1 in mesoderm and pre-endocardial cells, later spreading up into the dorsal aorta then primary head vein, intersomitic vessels, and limb bud vasculature, as would be consistent with a role in angiogenesis. Different class A Eph receptors have also been detected in the lining of the aorta, brachial arch arteries, umbilical vein, and endocardium. [29] Complementary expression of EphB2/ephrin-B4 was detected in developing arterial endothelial cells and EphB4 in venous endothelial cells. [30] Expression of EphB2 and ephrin-B2 was also detected on supportive mesenchymal cells, suggesting a role in wall development through mediation of endothelial-mesenchymal interactions. [31] Blood vessel formation during embryogenesis consists of vasculogenesis, the formation of a primary capillary network followed by a second remodeling and restructuring into a finer tertiary network - studies utilizing ephrin-B2 deficient mice showed a disruption of the embryonic vasculature as a result of a deficiency in the restructuring of the primary network. [18] Functional analysis of other mutant mice have led to the development of a hypothesis by which Ephs and ephrins contribute to vascular development by restricting arterial and venous endothelial mixing, thus stimulating the production of capillary sprouts as well as in the differentiation of mesenchyme into perivascular support cells, an ongoing area of research. [29]

Limb development

While there is currently little evidence to support this (and mounting evidence to refute it), some early studies implicated the Ephs to play a part in the signaling of limb development. [18] In chicks, EphA4 is expressed in the developing wing and leg buds, as well as in the feather and scale primordia. [32] This expression is seen in the distal end of the limb buds, where cells are still undifferentiated and dividing, and appears to be under the regulation of retinoic acid, FGF2, FGF4, and BMP-2 – known to regulate limb patterning. EphA4 defective mice do not present abnormalities in limb morphogenesis (personal communication between Andrew Boyd and Nigel Holder), so it is possible that these expression patterns are related to neuronal guidance or vascularisation of the limb with further studies being required to confirm or deny a potential role of Eph in limb development.

Cancer

As a member of the RTK family and with responsibilities as diverse as Ephs, it is not surprising to learn that the Ephs have been implicated in several aspects of cancer. While used extensively throughout development, Ephs are rarely detected in adult tissues. Elevated levels of expression and activity have been correlated with the growth of solid tumors, with Eph receptors of both classes A and B being over expressed in a wide range of cancers including melanoma, breast, prostate, pancreatic, gastric, esophageal, and colon cancer, as well as hematopoietic tumors. [33] [34] [35] Increased expression was also correlated with more malignant and metastatic tumors, consistent with the role of Ephs in governing cell movement. [29]

It is possible that the increased expression of Eph in cancer plays several roles, first, by acting as survival factors or as a promoter of abnormal growth. [36] The angiogenic properties of the Eph system may increase vascularisation of and thus growth capacity of tumors. [29] Second, elevated Eph levels may disrupt cell-cell adhesion via cadherin, known to alter expression and localisation of Eph receptors and ephrins, which is known to further disrupt cellular adhesion, a key feature of metastatic cancers. [36] Third, Eph activity may alter cell matrix interactions via integrins by the sequestering of signaling molecules following Eph receptor activation, as well as providing potential adherence via ephrin ligand binding following metastasis. [35] [36]

Discovery and history

The Eph receptors were initially identified in 1987 following a search for tyrosine kinases with possible roles in cancer, earning their name from the erythropoietin-producing hepatocellular carcinoma cell line from which their cDNA was obtained. [37] These transmembranous receptors were initially classed as orphan receptors with no known ligands or functions, and it was some time before possible functions of the receptors were known. [20]

When it was shown that almost all Eph receptors were expressed during various well-defined stages of development in assorted locations and concentrations, a role in cell positioning was proposed, initiating research that revealed the Eph/ephrin families as a principle cell guidance system during vertebrate and invertebrate development. [38]

Related Research Articles

<span class="mw-page-title-main">Ephrin</span> Family of proteins

Ephrins are a family of proteins that serve as the ligands of the Eph receptor. Eph receptors in turn compose the largest known subfamily of receptor protein-tyrosine kinases (RTKs).

<span class="mw-page-title-main">Ephrin B2</span> Protein-coding gene in the species Homo sapiens

Ephrin-B2 is a protein that in humans is encoded by the EFNB2 gene.

<span class="mw-page-title-main">Ephrin B1</span> Protein-coding gene in the species Homo sapiens

Ephrin B1 is a protein that in humans is encoded by the EFNB1 gene. It is a member of the ephrin family. The encoded protein is a type I membrane protein and a ligand of Eph-related receptor tyrosine kinases. It may play a role in cell adhesion and function in the development or maintenance of the nervous system.

<span class="mw-page-title-main">EPH receptor A2</span> Protein-coding gene in humans

EPH receptor A2 is a protein that in humans is encoded by the EPHA2 gene.

<span class="mw-page-title-main">EPH receptor B4</span> Protein-coding gene in the species Homo sapiens

Ephrin type-B receptor 4 is a protein that in humans is encoded by the EPHB4 gene.

<span class="mw-page-title-main">EPH receptor A4</span> Protein-coding gene in the species Homo sapiens

EPH receptor A4 is a protein that in humans is encoded by the EPHA4 gene.

<span class="mw-page-title-main">EPH receptor B1</span> Protein-coding gene in the species Homo sapiens

Ephrin type-B receptor 1 is a protein that in humans is encoded by the EPHB1 gene.

<span class="mw-page-title-main">EPH receptor A3</span> Protein-coding gene in the species Homo sapiens

EPH receptor A3 is a protein that in humans is encoded by the EPHA3 gene.

<span class="mw-page-title-main">EPHB6</span> Protein-coding gene in the species Homo sapiens

Ephrin type-B receptor 6 is a protein that in humans is encoded by the EPHB6 gene.

<span class="mw-page-title-main">EPHA8</span> Protein-coding gene in the species Homo sapiens

Ephrin type-A receptor 8 is a protein that in humans is encoded by the EPHA8 gene.

<span class="mw-page-title-main">EPHA7</span> Protein-coding gene in the species Homo sapiens

Ephrin type-A receptor 7 is a protein that in humans is encoded by the EPHA7 gene.

<span class="mw-page-title-main">EPH receptor A5</span> Protein-coding gene in the species Homo sapiens

EPH receptor A5 is a protein that in humans is encoded by the EPHA5 gene.

<span class="mw-page-title-main">Ephrin A4</span> Protein-coding gene in the species Homo sapiens

Ephrin A4 is a protein that in humans is encoded by the EFNA4 gene.

<span class="mw-page-title-main">Ephrin A2</span> Protein-coding gene in the species Homo sapiens

Ephrin-A2 is a protein that in humans is encoded by the EFNA2 gene.

<span class="mw-page-title-main">Ephrin A3</span> Protein-coding gene in the species Homo sapiens

Ephrin A3 is a protein that in humans is encoded by the EFNA3 gene.

<span class="mw-page-title-main">Ephrin B3</span> Protein-coding gene in the species Homo sapiens

Ephrin-B3 is a protein that in humans is encoded by the EFNB3 gene.

<span class="mw-page-title-main">EPH receptor A1</span> Protein-coding gene in the species Homo sapiens

EPH receptor A1 is a protein that in humans is encoded by the EPHA1 gene.

<span class="mw-page-title-main">EPHB3</span> Protein-coding gene in the species Homo sapiens

Ephrin type-B receptor 3 is a protein that in humans is encoded by the EPHB3 gene.

<span class="mw-page-title-main">Ephrin A5</span> Protein-coding gene in the species Homo sapiens

Ephrin A5 is a protein that in humans is encoded by the EFNA5 gene.

<span class="mw-page-title-main">Tropic cues involved in growth cone guidance</span>

The growth cone is a highly dynamic structure of the developing neuron, changing directionality in response to different secreted and contact-dependent guidance cues; it navigates through the developing nervous system in search of its target. The migration of the growth cone is mediated through the interaction of numerous trophic and tropic factors; netrins, slits, ephrins and semaphorins are four well-studied tropic cues (Fig.1). The growth cone is capable of modifying its sensitivity to these guidance molecules as it migrates to its target; this sensitivity regulation is an important theme seen throughout development.

References

  1. ↑ Egea J, Klein R (May 2007). "Bidirectional Eph-ephrin signaling during axon guidance". Trends Cell Biol. 17 (5): 230–8. doi:10.1016/j.tcb.2007.03.004. PMID   17420126.
  2. ↑ Rohani N, Canty L, Luu O, Fagotto F, Winklbauer R (March 2011). Hamada H (ed.). "EphrinB/EphB signaling controls embryonic germ layer separation by contact-induced cell detachment". PLOS Biol. 9 (3): e1000597. doi: 10.1371/journal.pbio.1000597 . PMC   3046958 . PMID   21390298.
  3. ↑ Davy A, Soriano P (January 2005). "Ephrin signaling in vivo: look both ways". Dev. Dyn. 232 (1): 1–10. doi: 10.1002/dvdy.20200 . PMID   15580616. S2CID   37808863.
  4. 1 2 Kullander K, Klein R (July 2002). "Mechanisms and functions of Eph and ephrin signalling". Nat. Rev. Mol. Cell Biol. 3 (7): 475–86. doi:10.1038/nrm856. PMID   12094214. S2CID   1735440.
  5. ↑ Kuijper S, Turner CJ, Adams RH (July 2007). "Regulation of angiogenesis by Eph-ephrin interactions". Trends Cardiovasc. Med. 17 (5): 145–51. doi:10.1016/j.tcm.2007.03.003. PMID   17574121.
  6. ↑ Genander M, Frisén J (October 2010). "Ephrins and Eph receptors in stem cells and cancer". Curr. Opin. Cell Biol. 22 (5): 611–6. doi:10.1016/j.ceb.2010.08.005. PMID   20810264.
  7. ↑ Eph Nomenclature Committee (August 1997). "Unified nomenclature for Eph family receptors and their ligands, the ephrins". Cell. 90 (3): 403–4. doi: 10.1016/S0092-8674(00)80500-0 . PMID   9267020.
  8. ↑ Pitulescu ME, Adams RH (November 2010). "Eph/ephrin molecules--a hub for signaling and endocytosis". Genes Dev. 24 (22): 2480–92. doi:10.1101/gad.1973910. PMC   2975924 . PMID   21078817.
  9. ↑ Pasquale EB (October 1997). "The Eph family of receptors". Curr. Opin. Cell Biol. 9 (5): 608–15. doi:10.1016/S0955-0674(97)80113-5. PMID   9330863.
  10. ↑ Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, Vearing C, Geleick D, Feldheim DA, Boyd AW, Henkemeyer M, Nikolov DB (May 2004). "Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling". Nat. Neurosci. 7 (5): 501–9. doi:10.1038/nn1237. PMID   15107857. S2CID   15643420.
  11. 1 2 Himanen JP (February 2012). "Ectodomain structures of Eph receptors". Semin. Cell Dev. Biol. 23 (1): 35–42. doi:10.1016/j.semcdb.2011.10.025. PMID   22044883.
  12. ↑ Kalo MS, Pasquale EB (October 1999). "Multiple in vivo tyrosine phosphorylation sites in EphB receptors". Biochemistry. 38 (43): 14396–408. doi:10.1021/bi991628t. PMID   10572014.
  13. ↑ McClelland AC, Hruska M, Coenen AJ, Henkemeyer M, Dalva MB (May 2010). "Trans-synaptic EphB2-ephrin-B3 interaction regulates excitatory synapse density by inhibition of postsynaptic MAPK signaling". Proc. Natl. Acad. Sci. U.S.A. 107 (19): 8830–5. doi: 10.1073/pnas.0910644107 . PMC   2889310 . PMID   20410461.
  14. ↑ Xu, Q.; Malecka, K. L.; Fink, L.; Jordan, E. J.; Duffy, E.; Kolander, S.; Peterson, J. R.; Dunbrack, R. L. (1 December 2015). "Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases". Science Signaling. 8 (405): rs13. doi:10.1126/scisignal.aaa6711. PMC   4766099 . PMID   26628682.
  15. ↑ Daar IO (February 2012). "Non-SH2/PDZ reverse signaling by ephrins". Semin. Cell Dev. Biol. 23 (1): 65–74. doi:10.1016/j.semcdb.2011.10.012. PMC   3288889 . PMID   22040914.
  16. 1 2 3 4 Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL (April 2005). "Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains". Cell. 121 (1): 127–39. doi: 10.1016/j.cell.2005.01.020 . PMID   15820684.
  17. ↑ Jørgensen C, Sherman A, Chen GI, Pasculescu A, Poliakov A, Hsiung M, Larsen B, Wilkinson DG, Linding R, Pawson T (December 2009). "Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells". Science. 326 (5959): 1502–9. doi:10.1126/science.1176615. PMID   20007894. S2CID   19333476.
  18. 1 2 3 4 Holder N, Klein R (May 1999). "Eph receptors and ephrins: effectors of morphogenesis". Development. 126 (10): 2033–44. doi:10.1242/dev.126.10.2033. PMID   10207129.
  19. ↑ Durbin L, Brennan C, Shiomi K, Cooke J, Barrios A, Shanmugalingam S, Guthrie B, Lindberg R, Holder N (October 1998). "Eph signaling is required for segmentation and differentiation of the somites". Genes Dev. 12 (19): 3096–109. doi:10.1101/gad.12.19.3096. PMC   317186 . PMID   9765210.
  20. 1 2 Flanagan JG, Vanderhaeghen P (1998). "The ephrins and Eph receptors in neural development". Annu. Rev. Neurosci. 21: 309–45. doi:10.1146/annurev.neuro.21.1.309. PMID   9530499.
  21. ↑ Triplett JW, Feldheim DA (February 2012). "Eph and ephrin signaling in the formation of topographic maps". Semin. Cell Dev. Biol. 23 (1): 7–15. doi:10.1016/j.semcdb.2011.10.026. PMC   3288406 . PMID   22044886.
  22. ↑ Petros TJ, Bryson JB, Mason C (September 2010). "Ephrin-B2 elicits differential growth cone collapse and axon retraction in retinal ganglion cells from distinct retinal regions". Dev Neurobiol. 70 (11): 781–94. doi:10.1002/dneu.20821. PMC   2930402 . PMID   20629048.
  23. ↑ Cheng HJ, Nakamoto M, Bergemann AD, Flanagan JG (August 1995). "Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map". Cell. 82 (3): 371–81. doi:10.1016/0092-8674(95)90426-3. hdl: 2164/10927 . PMID   7634327. S2CID   18009549.
  24. ↑ Gao PP, Zhang JH, Yokoyama M, Racey B, Dreyfus CF, Black IB, Zhou R (October 1996). "Regulation of topographic projection in the brain: Elf-1 in the hippocamposeptal system". Proc. Natl. Acad. Sci. U.S.A. 93 (20): 11161–6. doi: 10.1073/pnas.93.20.11161 . PMC   38301 . PMID   8855326.
  25. ↑ Kao TJ, Law C, Kania A (February 2012). "Eph and ephrin signaling: lessons learned from spinal motor neurons". Semin. Cell Dev. Biol. 23 (1): 83–91. doi:10.1016/j.semcdb.2011.10.016. PMID   22040916.
  26. ↑ Robinson V, Smith A, Flenniken AM, Wilkinson DG (November 1997). "Roles of Eph receptors and ephrins in neural crest pathfinding". Cell Tissue Res. 290 (2): 265–74. doi:10.1007/s004410050931. PMID   9321688. S2CID   9009347.
  27. ↑ George SE, Simokat K, Hardin J, Chisholm AD (Mar 1998). "The VAB-1 Eph receptor tyrosine kinase functions in neural and epithelial morphogenesis in C. elegans". Cell. 92 (5): 633–43. doi: 10.1016/s0092-8674(00)81131-9 . PMID   9506518.
  28. ↑ Chin-Sang ID, George SE, Ding M, Moseley SL, Lynch AS, Chisholm AD (Dec 1999). "The ephrin VAB-2/EFN-1 functions in neuronal signaling to regulate epidermal morphogenesis in C. elegans". Cell. 99 (7): 781–90. doi: 10.1016/s0092-8674(00)81675-x . PMID   10619431.
  29. 1 2 3 4 5 Cheng N, Brantley DM, Chen J (February 2002). "The ephrins and Eph receptors in angiogenesis". Cytokine Growth Factor Rev. 13 (1): 75–85. doi:10.1016/S1359-6101(01)00031-4. PMID   11750881.
  30. ↑ Wang HU, Chen ZF, Anderson DJ (May 1998). "Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4". Cell. 93 (5): 741–53. doi: 10.1016/S0092-8674(00)81436-1 . PMID   9630219.
  31. ↑ Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R (February 1999). "Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis". Genes Dev. 13 (3): 295–306. doi:10.1101/gad.13.3.295. PMC   316426 . PMID   9990854.
  32. ↑ Patel K, Nittenberg R, D'Souza D, Irving C, Burt D, Wilkinson DG, Tickle C (April 1996). "Expression and regulation of Cek-8, a cell to cell signalling receptor in developing chick limb buds" (PDF). Development. 122 (4): 1147–55. doi:10.1242/dev.122.4.1147. PMID   8620841.
  33. ↑ Wicks IP, Wilkinson D, Salvaris E, Boyd AW (March 1992). "Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines". Proc. Natl. Acad. Sci. U.S.A. 89 (5): 1611–5. doi: 10.1073/pnas.89.5.1611 . PMC   48502 . PMID   1311845.
  34. ↑ Kiyokawa E, Takai S, Tanaka M, Iwase T, Suzuki M, Xiang YY, Naito Y, Yamada K, Sugimura H, Kino I (July 1994). "Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors". Cancer Res. 54 (14): 3645–50. PMID   8033077.
  35. 1 2 Easty DJ, Herlyn M, Bennett DC (January 1995). "Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis". Int. J. Cancer. 60 (1): 129–36. doi:10.1002/ijc.2910600119. PMID   7814145. S2CID   42843769.
  36. 1 2 3 Surawska H, Ma PC, Salgia R (December 2004). "The role of ephrins and Eph receptors in cancer". Cytokine Growth Factor Rev. 15 (6): 419–33. doi:10.1016/j.cytogfr.2004.09.002. PMID   15561600.
  37. ↑ Murai KK, Pasquale EB (July 2003). "'Eph'ective signaling: forward, reverse and crosstalk". J. Cell Sci. 116 (Pt 14): 2823–32. doi: 10.1242/jcs.00625 . PMID   12808016.
  38. ↑ Boyd AW, Lackmann M (December 2001). "Signals from Eph and ephrin proteins: a developmental tool kit". Sci. STKE. 2001 (112): re20. doi:10.1126/stke.2001.112.re20. PMID   11741094. S2CID   2952319.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.